BKD Wealth Advisors LLC Has $806,000 Holdings in Medtronic PLC (MDT)
BKD Wealth Advisors LLC raised its position in Medtronic PLC (NYSE:MDT) by 32.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,080 shares of the medical technology company’s stock after buying an additional 2,227 shares during the period. BKD Wealth Advisors LLC’s holdings in Medtronic PLC were worth $806,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of the business. Vanguard Group Inc. boosted its position in Medtronic PLC by 4.5% in the 1st quarter. Vanguard Group Inc. now owns 102,321,656 shares of the medical technology company’s stock valued at $8,243,034,000 after buying an additional 4,412,536 shares during the last quarter. BlackRock Inc. boosted its position in Medtronic PLC by 2,513.4% in the 1st quarter. BlackRock Inc. now owns 87,035,376 shares of the medical technology company’s stock valued at $7,011,571,000 after buying an additional 83,705,052 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its position in Medtronic PLC by 3.0% in the 1st quarter. Massachusetts Financial Services Co. MA now owns 58,646,070 shares of the medical technology company’s stock valued at $4,724,526,000 after buying an additional 1,729,715 shares during the last quarter. Lazard Asset Management LLC boosted its position in Medtronic PLC by 1,061.4% in the 1st quarter. Lazard Asset Management LLC now owns 13,678,772 shares of the medical technology company’s stock valued at $1,101,960,000 after buying an additional 12,500,992 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in Medtronic PLC by 7.3% in the 1st quarter. Geode Capital Management LLC now owns 13,308,812 shares of the medical technology company’s stock valued at $1,070,622,000 after buying an additional 906,581 shares during the last quarter. 80.75% of the stock is owned by institutional investors.
ILLEGAL ACTIVITY WARNING: “BKD Wealth Advisors LLC Has $806,000 Holdings in Medtronic PLC (MDT)” was first posted by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this piece of content can be read at https://www.dailypolitical.com/2017/09/14/bkd-wealth-advisors-llc-has-806000-holdings-in-medtronic-plc-mdt.html.
Shares of Medtronic PLC (MDT) traded down 0.21% during mid-day trading on Thursday, reaching $81.76. 2,002,335 shares of the company were exchanged. Medtronic PLC has a 12 month low of $69.35 and a 12 month high of $89.72. The firm has a 50-day moving average price of $82.48 and a 200 day moving average price of $83.66. The stock has a market capitalization of $110.75 billion, a P/E ratio of 27.52 and a beta of 1.03.
Medtronic PLC (NYSE:MDT) last posted its quarterly earnings results on Tuesday, August 22nd. The medical technology company reported $1.12 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.08 by $0.04. The business had revenue of $7.39 billion during the quarter, compared to the consensus estimate of $7.44 billion. Medtronic PLC had a net margin of 13.75% and a return on equity of 12.92%. Medtronic PLC’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.03 earnings per share. Equities research analysts anticipate that Medtronic PLC will post $4.77 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 20th. Investors of record on Friday, September 29th will be issued a dividend of $0.46 per share. This represents a $1.84 dividend on an annualized basis and a yield of 2.25%. The ex-dividend date of this dividend is Thursday, September 28th. Medtronic PLC’s dividend payout ratio is currently 61.95%.
In related news, EVP Bryan C. Hanson sold 12,000 shares of the business’s stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $88.57, for a total transaction of $1,062,840.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard H. Anderson acquired 5,600 shares of the firm’s stock in a transaction that occurred on Wednesday, June 21st. The shares were purchased at an average price of $88.90 per share, with a total value of $497,840.00. Following the acquisition, the director now owns 71,910 shares of the company’s stock, valued at approximately $6,392,799. The disclosure for this purchase can be found here. 0.31% of the stock is currently owned by insiders.
MDT has been the topic of a number of recent analyst reports. William Blair restated an “outperform” rating on shares of Medtronic PLC in a research note on Thursday, July 6th. BidaskClub upgraded shares of Medtronic PLC from a “buy” rating to a “strong-buy” rating in a research note on Saturday, June 17th. Wells Fargo & Company restated an “outperform” rating on shares of Medtronic PLC in a research note on Wednesday, July 12th. Oppenheimer Holdings, Inc. restated a “buy” rating on shares of Medtronic PLC in a research note on Tuesday, July 18th. Finally, Needham & Company LLC restated a “buy” rating and issued a $95.00 target price (up previously from $91.00) on shares of Medtronic PLC in a research note on Thursday, May 25th. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and thirteen have issued a buy rating to the company. Medtronic PLC currently has an average rating of “Hold” and an average target price of $88.78.
Medtronic PLC Company Profile
Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.
Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with MarketBeat.com's FREE daily email newsletter.